一项国家审计发现,英格兰和威尔士在获得前列腺癌治疗方面存在重大差距,老年和黑人男子受影响最大。 A national audit finds major disparities in prostate cancer treatment access across England and Wales, with older and Black men most affected.

一项国家审计显示,在英格兰和威尔士,前列腺癌患者在获得延长生命的治疗方面存在巨大差距,69%在英格兰,68%在威尔士,接受激进治疗,约三分之一得不到治疗护理。 A national audit reveals significant disparities in access to life-extending treatments for prostate cancer patients in England and Wales, with 69% in England and 68% in Wales receiving radical therapy, leaving about one-third without curative care. 区域差异非常明显,从46%到87%不等,老年男子和黑人男子受到的影响特别大,往往在后期诊断出来。 Regional variation is stark, ranging from 46% to 87%, and older men and Black men are disproportionately affected, often diagnosed at later stages. 2024年,英格兰的诊断病例上升到58 218例,而威尔士则略有下降。 In 2024, diagnoses rose in England to 58,218, while Wales saw a slight decline. 在英格兰,约12%的病例和威尔士的20%的病例在诊断后得到诊断。 Around 12% of cases in England and 20% in Wales were advanced at diagnosis. 英国前列腺癌协会称,不平等的获得机会是不可接受的,理由是没有国家筛查方案。 Prostate Cancer UK calls the unequal access unacceptable, citing the absence of a national screening program. 威尔士政府承认存在挑战,并强调正在努力通过其癌症改善计划提高护理的一致性。 The Welsh Government acknowledges challenges and highlights ongoing efforts to improve care consistency through its cancer improvement plan.